Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TLV/TGTR stock hub

TLV/TGTR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/TGTRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

46.4M

Tel Aviv Stock Exchange

Market data

Price

Recent price action with selectable time range.

TLV/TGTRTLV/TGTR

—

Loading chart…

In the news

Latest news · TLV/TGTR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E22.3

P25 n/aP50 n/aP75 n/a

ROE4.3

P25 n/aP50 n/aP75 n/a

ROIC6.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/TGTR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

ILS

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	210
Employees Change	11%
Employees Change Percent	5.53
Enterprise value	ILA 96.1M
Exchange	Tel Aviv Stock Exchange
Financial currency	ILS
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	IL0004620105
Last refreshed	2026-05-10
Market cap	ILA 46.4M
Price	ILA 268
Price currency	ILA
Rev Per Employee	522,038.1x
Sector	Healthcare
Sic	7370
Symbol	tlv/TGTR
Website	https://www.together-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.12%
EV Earnings	50.24x
EV/EBIT	6.31x
EV/EBITDA	4.22x
EV/FCF	18.59x
EV/Sales	0.88x
FCF yield	11.13%
P/B ratio	0.93x
P/E ratio	22.3x
P/S ratio	0.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.89%
EBITDA Margin	19.41%
FCF margin	4.71%
Gross margin	28.72%
Gross Profit	ILA 31.5M
Gross Profit Growth	83.97%
Gross Profit Growth3 Y	-4.96%
Gross Profit Growth5 Y	11.25%
Net Income	ILA 1.9M
Net Income Growth Quarters	2%
Net Income Growth Years	3%
Pretax Margin	4.45%
Profit Margin	1.74%
Profit Per Employee	ILA 9,105
Profitable Years	1
ROA	6.32
Roa5y	0.89
ROCE	18.42
ROE	4.34
Roe5y	-280.5
ROIC	6.14
Roic5y	-18.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-21.21%
Cagr1y	-35.52%
Cagr3y	0.84%
Cagr5y	-30.65%
Div CAGR10	-13.27%
Div CAGR3	-37.78%
Div CAGR5	-24.77%
EPS Growth Quarters	2
EPS Growth Years	3
FCF Growth	275.98%
FCF Growth3 Y	-21.85%
FCF Growth5 Y	1.92%
OCF Growth	130.96%
OCF Growth3 Y	-19.59%
OCF Growth5 Y	5.79%
Revenue Growth	14.13x
Revenue Growth Q	0.9x
Revenue Growth Quarters	2x
Revenue Growth Years	5x
Revenue Growth3 Y	4.56x
Revenue Growth5 Y	10.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.73
Assets	ILA 154M
Cash	ILA 12.2M
Current Assets	ILA 94M
Current Liabilities	ILA 71.3M
Debt	ILA 59.7M
Debt EBITDA	ILA 2.62
Debt Equity	ILA 1.19
Debt FCF	ILA 11.57
Equity	ILA 50.1M
Interest Coverage	2.26
Liabilities	ILA 103.8M
Long Term Assets	ILA 60M
Long Term Liabilities	ILA 32.5M
Net Cash	ILA -47.5M
Net Cash By Market Cap	ILA -102
Net Debt EBITDA	ILA 2.23
Net Debt Equity	ILA 0.95
Net Debt FCF	ILA 9.2
Tangible Book Value	ILA 23.6M
Tangible Book Value Per Share	ILA 1.36
WACC	4.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.32
Inventory Turnover	1.31
Net Working Capital	ILA 44.4M
Quick ratio	0.41
Working Capital	ILA 22.7M
Working Capital Turnover	ILA 7.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.26%
Dividend per share	ILA 0
Last Dividend	ILA 0.29

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-90.77%
1Y total return	-35.5%
200-day SMA	343.6
3Y total return	2.53%
50-day SMA	292
50-day SMA vs 200-day SMA	50under200
5Y total return	-83.96%
All Time High	31,880
All Time High Change	-99.16%
All Time High Date	2012-07-31
All Time Low	231
All Time Low Change	15.84%
All Time Low Date	2022-12-29
ATR	12.33
Beta	0.24
Beta1y	0
Beta2y	0.2
Ch YTD	-20.1
High	268
High52	440
High52 Date	2025-05-14
High52ch	-39.18%
Low	267
Low52	252.1
Low52 Date	2026-03-31
Low52ch	6.15%
Ma50ch	-8.37%
Price vs 200-day SMA	-22.12%
RSI	43.35
RSI Monthly	38.07
RSI Weekly	13.4
Sharpe ratio	-1.53x
Sortino ratio	-1.95
Total Return	-27.26%
Tr YTD	-20.1
Tr1m	-4.73%
Tr1w	-0.22%
Tr3m	-23.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA 15.2M
Operating Income Growth	3,960.8
Operating Income Growth3 Y	-13.68
Operating Income Growth5 Y	23.91
Operating margin	13.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,311,331%
Net Borrowing	4,078,000
Shares Insiders	75.15%
Shares Out	17,346,934
Shares Qo Q	21.96%
Shares Yo Y	27.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA 5.2M
Average Volume	11,353.2x
Bv Per Share	2.77
CAPEX	ILA -1.4M
Ch10y	-90.77
Ch1m	-4.73
Ch1w	-0.22
Ch1y	-35.5
Ch3m	-23.06
Ch3y	2.53
Ch5y	-83.96
Ch6m	-18.86
Change	-0.15%
Change From Open	-0.15
Close	268
Days Gap	0
Depreciation Amortization	6,047,000
Dollar Volume	1,801,483.2
Earnings Date	2026-05-29
EBIT	ILA 15.2M
EBITDA	ILA 21.3M
EPS	ILA 0.12
F Score	7
FCF	ILA 5.2M
FCF EV Yield	5.38x
FCF Per Share	ILA 0.3
Financing CF	4,078,000
Fiscal Year End	December
Founded	1,991
Goodwill	16,175,000
Graham Number	2.73408
Graham Upside	-98.98
Income Tax	ILA 3M
Investing CF	-6,883,000
Is Primary Listing	1
Last Earnings Date	2025-11-27
Last Report Date	2025-12-31
Last Split Date	2023-08-13
Last Split Type	Reverse
Ma150	328.4
Ma150ch	-18.52%
Ma20	269.4
Ma20ch	-0.66%
Net CF	3,775,000
Next Earnings Date	2026-05-29
Open	268
P FCF Ratio	8.99
P OCF Ratio	7.05
Position In Range	60
Ppne	33,064,000
Price Date	2026-05-08
Price EBITDA	ILA 2.18
Ptbv Ratio	1.97
Relative Volume	0.61x
Revenue	109,628,000x
Tax By Revenue	2.7x
Tax Rate	60.64%
Tr6m	-18.86%
Volume	6,732
Z Score	-0.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/TGTR pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/TGTR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/TGTR?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+75.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+27.3%

Negative means the company is buying back shares.

Technical

TLV/TGTR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.4

Neutral momentum band

Price vs 200-day MA

-22.1%

50/200-day relationship not available

Beta (5Y)

0.24

Less volatile than the market

Sharpe ratio

-1.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/TGTR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/TGTR stock rating?

tlv/TGTR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/TGTR analysis?

The full report lives at /stocks/tlv/TGTR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/TGTR?

The latest report frames tlv/TGTR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/TGTR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.